This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Reliance Life Sciences Pvt. Ltd.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Innovations by Vijay Gangan in Lipase-Mediated Disease Treatment
Introduction
Vijay Gangan is an accomplished inventor based in Navi Mumbai, India. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of lipase-mediated diseases. His innovative work has led to the development of novel compounds that have the potential to address various health conditions.
Latest Patents
Vijay Gangan holds a patent for "Compounds for treatment of lipase-mediated diseases." This patent includes novel benzoquinone-derived compounds and their polymorphs, prodrugs, and isomers. The compounds are designed to reduce or inhibit the activity of the lipase gene family, which is crucial for treating conditions such as overweight, obesity, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, pancreatitis, diabetes, atherosclerosis, and other cardiovascular diseases. Additionally, methods for using these compounds in skin care, hair care, and cosmetics are also provided.
Career Highlights
Vijay Gangan is currently associated with Reliance Life Sciences Pvt. Ltd., where he continues to innovate and develop new pharmaceutical solutions. His work is characterized by a strong focus on addressing metabolic syndromes and disorders through advanced chemical compounds.
Collaborations
Some of his notable coworkers include Shakti N Upadhyay and Raman P Yadav, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Vijay Gangan's contributions to the field of pharmaceuticals through his innovative patents highlight his commitment to improving health outcomes for individuals suffering from lipase-mediated diseases. His work exemplifies the impact of scientific research on real-world health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
